As of 2024-12-12, the Relative Valuation of Rua Life Sciences PLC (RUA.L) is (78.60) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 11.50 GBP, the upside of Rua Life Sciences PLC based on Relative Valuation is -783.5%.
The range of the Relative Valuation is (75.46) - (86.13) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.5x - 37.7x | 35.1x |
| Forward P/E multiples | 28.2x - 37.1x | 32.6x |
| Fair Price | (75.46) - (86.13) | (78.60) |
| Upside | -756.1% - -849.0% | -783.5% |
| Date | P/E |
| 2024-11-29 | -4.71 |
| 2024-11-28 | -4.71 |
| 2024-11-27 | -4.75 |
| 2024-11-26 | -4.63 |
| 2024-11-25 | -4.63 |
| 2024-11-22 | -4.96 |
| 2024-11-21 | -4.96 |
| 2024-11-20 | -5.06 |
| 2024-11-19 | -4.85 |
| 2024-11-18 | -4.85 |
| 2024-11-15 | -4.96 |
| 2024-11-14 | -5.39 |
| 2024-11-13 | -4.85 |
| 2024-11-12 | -4.85 |
| 2024-11-11 | -4.81 |
| 2024-11-08 | -4.63 |
| 2024-11-07 | -4.96 |
| 2024-11-06 | -4.96 |
| 2024-11-05 | -4.96 |
| 2024-11-04 | -4.96 |
| 2024-11-01 | -4.96 |
| 2024-10-31 | -4.85 |
| 2024-10-30 | -4.96 |
| 2024-10-29 | -5.49 |
| 2024-10-28 | -5.39 |
| 2024-10-25 | -5.49 |
| 2024-10-24 | -5.49 |
| 2024-10-23 | -5.82 |
| 2024-10-22 | -6.14 |
| 2024-10-21 | -6.14 |
| 2024-10-18 | -6.14 |
| 2024-10-17 | -6.14 |
| 2024-10-16 | -6.25 |
| 2024-10-15 | -6.36 |
| 2024-10-14 | -6.36 |
| 2024-10-11 | -6.36 |
| 2024-10-10 | -6.36 |
| 2024-10-09 | -6.14 |
| 2024-10-08 | -5.93 |
| 2024-10-07 | -5.93 |
| 2024-10-04 | -6.25 |
| 2024-10-03 | -6.25 |
| 2024-10-02 | -5.60 |
| 2024-10-01 | -6.03 |
| 2024-09-30 | -5.82 |
| 2024-09-27 | -5.17 |
| 2024-09-26 | -5.28 |
| 2024-09-25 | -5.28 |
| 2024-09-24 | -5.39 |
| 2024-09-23 | -5.44 |